Baidu
map

NEJM:西雅图地区新冠肺炎危重病例研究

2020-04-02 MedSci原创 MedSci原创

美国西雅图地区新冠肺炎危重患者接受ICU治疗的最常见原因是低氧性呼吸衰竭和或低血压,且这些病人的死亡率很高

2020年2月,华盛顿州报告了2019年冠状病毒(Covid-19)的社区传播病例。
 
近日,研究人员对西雅图9家医院中入住重症监护病房(ICU)的新冠肺炎重症患者数据进行了分析,患者证实感染了严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)。通过查阅病历获得临床资料,每个病人至少随访14天。
 
总计24例Covid-19患者参与研究,平均年龄为64岁,63%为男性,平均入院前7天开始出现症状。最常见的症状是咳嗽和呼吸急促;50%的患者入院时发烧,58%有糖尿病。所有患者均因低氧性呼吸衰竭入院,75%(18例)需要机械通气。大多数患者(17)伴有低血压,需要使用升压药。没有患者检测出甲型流感、乙型流感或其他呼吸道病毒。半数患者(12人)在ICU第1天至第18天期间死亡,其中4例患者入院时家属提出不复苏指令。在12名幸存患者中,5人出院回家,4人从重症监护室转出但仍留院治疗,3人继续在ICU接受机械通气。
 
研究认为,美国西雅图地区新冠肺炎危重患者接受ICU治疗的最常见原因是低氧性呼吸衰竭和或低血压,且这些病人的死亡率很高。
 
原始出处:
 
Pavan K. Bhatraju et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med, March 30, 2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016402, encodeId=cd1b20164024b, content=<a href='/topic/show?id=0fa1e0783cb' target=_blank style='color:#2F92EE;'>#病例研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70783, encryptionId=0fa1e0783cb, topicName=病例研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Jan 13 14:56:15 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690478, encodeId=0e7016904e8a3, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Jun 21 15:56:15 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027607, encodeId=324e102e6073f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035206, encodeId=c4861035206f3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016402, encodeId=cd1b20164024b, content=<a href='/topic/show?id=0fa1e0783cb' target=_blank style='color:#2F92EE;'>#病例研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70783, encryptionId=0fa1e0783cb, topicName=病例研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Jan 13 14:56:15 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690478, encodeId=0e7016904e8a3, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Jun 21 15:56:15 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027607, encodeId=324e102e6073f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035206, encodeId=c4861035206f3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016402, encodeId=cd1b20164024b, content=<a href='/topic/show?id=0fa1e0783cb' target=_blank style='color:#2F92EE;'>#病例研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70783, encryptionId=0fa1e0783cb, topicName=病例研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Jan 13 14:56:15 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690478, encodeId=0e7016904e8a3, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Jun 21 15:56:15 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027607, encodeId=324e102e6073f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035206, encodeId=c4861035206f3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=)]
    2020-04-02 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2016402, encodeId=cd1b20164024b, content=<a href='/topic/show?id=0fa1e0783cb' target=_blank style='color:#2F92EE;'>#病例研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70783, encryptionId=0fa1e0783cb, topicName=病例研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Jan 13 14:56:15 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690478, encodeId=0e7016904e8a3, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Jun 21 15:56:15 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027607, encodeId=324e102e6073f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035206, encodeId=c4861035206f3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 02 21:56:15 CST 2020, time=2020-04-02, status=1, ipAttribution=)]
    2020-04-02 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

JAMA:ICU应激性溃疡预防策略与死亡率——PPI vs H2RB

研究发现,在需要机械通气的ICU患者中,使用质子泵抑制剂或组胺-2受体阻滞剂作为应激性溃疡预防策略导致的医院死亡率无显著性差异。

战疫者|武汉肺科医院ICU主任:连轴转720小时

2月1日,武汉,晴转阴。这座被新型冠状病毒肺炎阴影“笼罩”的城中,最美的身影仍属于奋战在抗疫一线的人们。武汉肺科医院仁医楼十三层的重症监护室(ICU),收治着数十名“危重新型冠状病毒肺炎病人”,他们正接受进一步治疗。记者见到ICU主任胡明时,他正身穿暗绿色短袖工作制服、满头大汗从重症监护室走出来。在此之前,他刚和其他几名教授完成一次ECMO(移动心肺仪)病人的转移,约50米的距离,耗时近40分

JAMA:ICU患者感染事件发生率及临床结局

接受ICU治疗患者疑似或证实感染风险很高,导致住院死亡率增加

NEJM:轻度镇静或不镇静对ICU通气患者死亡率的影响

在ICU机械通气患者中,无镇静或每日中断轻度镇静组间90天的死亡率无显著差异

2020 SCCM指南:ICU内成人急性和慢加急性肝衰竭的管理

2020年2月,美国重症医学会(SCCM)发布了ICU内成人急性和慢加急性肝衰竭的管理指南,主要目的是为ICU内成人急性和慢加急性肝衰竭的管理提供循证指导建议。共29条建议涉及五类情况即,心血管、血液、肺脏、肾脏和内分泌。

ICU医生眼里的ICU:与死神抗争,也要尊重人性

在多数人印象中,ICU(重症监护室)既神秘又让人敬畏。里面的患者全身插满管子,监护仪的报警声此起彼伏,炽烈的灯光昼夜长明,不时会有患者因抢救无效死亡。

Baidu
map
Baidu
map
Baidu
map